-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA - HLP003 DEMONSTRATES SIGNIFICANT RESPONSE AND REMISSION RATES FROM DAY 2 IN PHASE 3 STUDY

Reuters·11/16/2026 12:00:03

Please log in to view news